AUS
NZ
UK
CA
USA
IND
Healthcare
More Discoveries On Horizon In Medical Cannabis Research
November 19, 2018 03:51 AM AEDT| By Team Kalkine MediaTo improve the treatment of everything from anxiety to multiple sclerosis, medical cannabis is already used. MGC Pharma says there are more cannabis-focused medical discoveries with which the medical research is set to receive a big lift. Today the...
ASX: RAP - A Sinusoidal Trend Witnessed Post Performance Update Release
November 16, 2018 09:05 AM AEDT| By Team Kalkine MediaResApp Health Limited (ASX: RAP) has recently presented an update on its performance from various studies and approvals received as on November 15, 2018. While addressing the shareholders, Chief Executive Officer and Managing Director of RAP, Tony K...
Mesoblast’s Strong Quarter Results Failed To Lift The Share Price
November 16, 2018 08:46 AM AEDT| By Team Kalkine MediaMesoblast Limited (ASX: MSB) presented its financial and operating metrics for the first quarter ended on September 30, 2018 on November 16, 2018, i.e. today. MSB reported an increase of US$10.5m in revenues up to US$11.6 million for the first quart...
Pharmaxis’ Upside Move After The Positive Trial Results
November 15, 2018 12:07 PM AEDT| By Team Kalkine MediaOn November 15, 2018, Pharmaxis Limited (ASX: PXS) announced about the Phase 1 clinical trial results. The trial was done to study the outcome from the inhibitor compound LOXL2 (Lysyl Oxidase Like 2) that is used for the treatment of fibrotic disease...
Paradigm Biopharmaceuticals Slips On ASX Post Announcement About R&D Tax Incentive Refund
November 15, 2018 06:39 AM AEDT| By Team Kalkine MediaParadigm Biopharmaceuticals Ltd (ASX: PAR) has received R&D tax incentive refund from the Australian Government on November 15, 2018, i.e. today. The company has received a R&D tax incentive refund of $2.32m. The refund from the Aussie autho...
Creso Pharma Slips After An Agreement With Virbac
November 15, 2018 05:54 AM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH) has entered into an exclusive distribution agreement with the Virbac Group and the announcement for the same was made on November 14, 2018. Under this distribution agreement, expansion of the commercialization and dist...
Imugene Rebounds On Receiving Tax Rebate And Advancement To Phase 2 In Gastric Cancer Trial
November 14, 2018 05:04 AM AEDT| By Team Kalkine MediaImugene Limited (ASX: IMU), the immuno-oncology company, with its unique technological platform basically tries to harness the immune system of the cancer patients and helps in the generation of the antibodies that can fight against tumors and comple...
Factor Therapeutics Limited Witnessed A Free Fall After Failed Clinical Trial Results
November 14, 2018 04:24 AM AEDT| By Team Kalkine MediaFactor Therapeutics Limited (ASX: FTT) has its lead program called ?VF001? that has been developed for the treatment of ulcers. The lead program VF001 is currently in stage 2. On November 14, 2018, FTT presented the results from the clinical trial co...
Ramsay Health Care Ltd Shares Advance Higher Post Annual General Meeting
November 14, 2018 02:24 AM AEDT| By Team Kalkine MediaRamsay Health Care Limited (ASX: RHC) held its Annual general meeting on 14 November 2018, following which the share price of the company were seen to be uplifted by 1.334 percent (1:10 PM AEST). In FY 2018, Ramsay Health Care reported a Core Net Pro...
3 Healthcare Stocks - NAN, BNO And SOM
November 13, 2018 02:09 PM AEDT| By Team Kalkine MediaNanosonics Limited (ASX: NAN) Nanosonics Limited (ASX: NAN) is a health care company which received very pleasing results in FY 2018 with sales of $60.7 million and a pre-tax profit of $5.6 million contributing to a further increase in the cash bala...
MediPharm Labs Bags A Sales License For Canada
November 13, 2018 05:37 AM AEDT| By Team Kalkine MediaMMJ Group Holdings Limited (ASX:MMJ), which owns 5.2 million shares and 2.9 million warrants (exercisable at CAD $1.20 per share by October 2020) in MediPharm Labs came up with the media release announcement on November 13, 2018. Pursuant to the Cann...
Althea Group Slips After Securing Medicinal Cannabis Export License
November 13, 2018 04:52 AM AEDT| By Team Kalkine MediaAlthea Group Holdings Limited (ASX:AGH) came up with the announcement regarding the grant of export license to its wholly owned subsidiary Althea Company Pty Ltd by the Australian Government?s Office of Drug Control (ODC) on November 13, 2018. Under...
The Price Of Phosphagenics Tumbled By 89% After The Company Loses The Court Case
November 12, 2018 03:59 PM AEDT| By Team Kalkine MediaThe investors of Phosphagenics Limited (ASX: POH) experienced a set back after the company has lost a significant claim against big pharmaceuticals company Mylan. The share of the company plunged terribly by 85% when the market opened this morning....
Immutep Tumbles Despite The Release Of Positive New Data From Ongoing TACTI-Mel
November 12, 2018 03:07 PM AEDT| By Team Kalkine MediaImmutep Ltd (ASX: IMM), a biotechnology company, which develops immunotherapy treatments for cancer and autoimmune diseases, has ?IMP 321? or ?efti? eftilagimod alpha as the current lead product. IMP 321 is known to be a soluble LAG - 3 lg? protein t...
Mesoblast Limited Slips Post Releasing Phase 2 Trial Result
November 12, 2018 07:35 AM AEDT| By Team Kalkine MediaMesoblast Limited (ASX:MSB) presented the results of the phase 2 trial from the test conducted on 159 patients, on November 12, 2018. The end results from the test conducted by the implantation of the left ventricular assist device on the heart failu...
Healthscope Opens With A Gap-Up After Receiving A Proposal From Brookfield
November 12, 2018 04:45 AM AEDT| By Team Kalkine MediaHealthscope Limited (ASX: HSO) received a ?Takeover Offer? from Brookfield Capital Partners Ltd, as announced on November 12, 2018. Brookfield Capital Partners Ltd along with its affiliate partners and managed funds presented a proposal to have 100%...
Proteomics International Laboratories Advances On Key Performance Results Of PromarkerD Kit
November 09, 2018 11:58 AM AEDT| By Team Kalkine MediaProteomics International Laboratories Limited (ASX: PIQ) came up with performance results of PromarkerD immunoassay kit. The results were presented on November 9, 2018 at the 18th Annual Diabetes Technology meeting held between November 08, and Novem...
Nanosonics Slightly Bounces Back After The AGM
November 09, 2018 04:33 AM AEDT| By Team Kalkine MediaNanosonics Limited (ASX: NAN) had its Annual General Meeting on November 9, 2018, i.e. today. Strengthening its position internationally, NAN has delivered an outstanding series of milestones virtually across all dimensions of the business. Company i...
Suda Pharmaceuticals Is All Set To Commercialize SUD-001H
November 08, 2018 08:43 AM AEDT| By Team Kalkine MediaSuda Pharmaceuticals Limited (ASX:SUD) announced regarding its entry into an?exclusive product development, licence and supply agreement with the fully owned subsidiary of Strides Pharma Science Ltd, Strides Pharma Global Pte Ltd on November 8, 2018....
ResMed Slips After Acquisition Update
November 06, 2018 08:40 AM AEDT| By Team Kalkine MediaResMed Inc (ASX:RMD) has issued a press release on November 6, 2018, announcing its entry into an agreement and plan of merger of ResMed operations Inc, a Delaware corporation and a wholly owned subsidiary of ResMed Operations MatrixCare Holdings, In...
Advertise your brand on Kalkine Media